Status:

NOT_YET_RECRUITING

Cephalic Femoral Heads Follow Up

Lead Sponsor:

Limacorporate S.p.a

Conditions:

Hip Arthroplasty Replacement

Femoral Fractures

Eligibility:

All Genders

18+ years

Brief Summary

Study design: monocentric, retrospective, observational and post-market clinical study. Purpose: To demonstrate the safety and performance of cephalic femoral heads. The eligible study population is ...

Detailed Description

The study is aiming to demoranstrate safety and performance of cephalic femoral heads and will do it by considering the rate of revision of any prosthesis component and dislocation, by x-ray evaluatio...

Eligibility Criteria

Inclusion

  • Displaced intracapsular hip fracture (Garden III-IV).
  • Subjects underwent a Unipolar Hemiarthroplasty with a Cephalic femoral head as per their Indication For Use from January 1st, 2023, onwards.
  • No concurrent joint disease at the time of the surgery.
  • Absence of severe cognitive dysfunction demonstrated by 3 or more correct answers on the Pfeiffer test.
  • Ability to ambulate independently with or without walking aids before surgery.
  • Subject willingness to participate.

Exclusion

  • Undisplaced or minimally displaced intracapsular hip fracture (Garden I-II).
  • Any Cephalic femoral head contraindication for use as reported in the current Instruction For Use.
  • Pathological fracture secondary to malignant disease.
  • Subjects with rheumatoid arthritis or symptomatic osteoarthritis.
  • Previous treatment to the same hip for a fracture at the time of the surgery.
  • Subjects who were deemed unsuitable for the surgical procedures by the anesthesiologist.
  • Severe cognitive dysfunction or cognitive impairment demonstrated by 2 or less correct answers on the Pfeiffer test.
  • Unable to walk before surgery (e.g., wheelchair or bed-ridden subjects).

Key Trial Info

Start Date :

October 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT06873568

Start Date

October 1 2025

End Date

December 1 2027

Last Update

March 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital J.A. Reimana

Prešov, Slovakia, 5898